College of Veterinary Medicine
Information For
 
 Alumni
 Animal Owners
 Donors & Friends
 Faculty & Staff
 Researchers
 Students
 Veterinarians
 
College Links
 
 About
 Directory
 Employment
 Map/Directions
 Volunteer
 
CVM Web Sites

 

Search

 

 

Make a Gift box

  Home > News Archives > News Archives 2002-2004 > Benefits of Antibiotics in Chickens May Outweigh Risks
 

Benefits of Antibiotics in Chickens May Outweigh Risks

NEWS RELEASE
For Immediate Release

Contact:
Jan Williams, U of M College of Veterinary Medicine, 612-624-6228
Molly Portz, U of M Academic Health Center, 612-625-2640
Tracy Stone, 646-489-1412 (ICAAC on-site contact)

MINNEAPOLIS / ST. PAUL (November 2, 2004) - The potential benefits to human health associated with the use of antibiotics in chicken may outweigh the potential risks, according to a risk-benefit analysis conducted by a team of researchers led by Randall S. Singer, D.V.M., Ph.D., of the University of Minnesota College of Veterinary Medicine. Recent studies have shown that antibiotic use in animal production results in healthier animals, and the meat derived from these healthier animals has lower levels of bacteria that can cause food-borne illness in people. Other evidence indicates however, that the use of antibiotics also has the potential to increase the level of antibiotic-resistant bacteria in meat. The researchers developed a mathematical model to evaluate the potential human health risks and benefits of the use of the antibiotic tylosin in chickens. They compared the potential risks associated with increased levels of antibiotic-resistant bacteria in meat with the potential benefits associated with decreased risk of food-borne illness.

"Antibiotic resistance is a problem in both human medicine and animal production animal agriculture," Singer said. "But our model demonstrated that the reduced number of infections and illness days associated with the use of tylosin in chicken far exceeded the increased human health risks associated with antibiotic resistance due to tylosin use."

Singer will present the results of the study at the annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, D.C., on Nov. 2. The presentation will be one of many on antibiotic resistance, bioterrorism, and infectious disease, all of which are hot topics in veterinary medicine as well as human medicine.

"Veterinarians have a commitment to both animal and human health - which are strongly connected," said Jeff Klausner, dean of the College of Veterinary Medicine at the University of Minnesota. "At the University of Minnesota, the Center for Animal Health and Food Safety is actively addressing many of these issues."

In addition to Singer, the authors of the study were L. Anthony Cox, Cox Associates, Denver, Colo.; James S. Dickson and H. Scott Hurd, Iowa State University, Ames, Iowa; Ian Phillips, University of London, London; and Gay Y. Miller, University of Illinois, Urbana, Ill. The study was funded by Elanco, the animal health division of Eli Lilly and Company.

-end-

The College of Veterinary Medicine improves the health and well-being of animals and people by providing high-quality veterinary training, conducting leading-edge research, and delivering innovative veterinary services.


Notice of Privacy Practices